feed,title,long_url,short_url
Benzinga,Gilead's Trodelvy New Subgroup Data Shows Benefit in Second-Line Breast Cancer Patients,https://benzinga.com/general/biotech/21/06/21431577/gileads-trodelvy-new-subgroup-data-shows-benefit-in-second-line-breast-cancer-patients,https://j.mp/2Tz2riq
